Abstract
Objectives
To compare diagnostic accuracy of contrast-enhanced CT, dual-layer detector spectral CT (DL-CT), and whole-body MRI (WB-MRI) for diagnosing metastatic breast cancer.
Methods
One hundred eighty-two biopsy-verified breast cancer patients suspected of metastatic disease prospectively underwent contrast-enhanced DL-CT and WB-MRI. Two radiologists read the CT examinations with and without spectral data in consensus with 3-month washout between readings. Two other radiologists read the WB-MRI examinations in consensus. Lymph nodes, visceral lesions, and bone lesions were assessed. Readers were blinded to other test results. Reference standard was histopathology, previous or follow-up imaging, and clinical follow-up.
Results
Per-lesion AUC was 0.80, 0.84, and 0.82 (CT, DL-CT, and WB-MRI, respectively). DL-CT showed significantly higher AUC than CT (p = 0.001) and WB-MRI (p = 0.02). Sensitivity and specificity of CT, DL-CT, and WB-MRI were 0.66 and 0.94, 0.75 and 0.95, and 0.65 and 0.98, respectively. DL-CT significantly improved sensitivity compared to CT (p < 0.0001) and WB-MRI (p = 0.002). Per-patient AUC was 0.85, 0.90, and 0.92 (CT, DL-CT, and WB-MRI, respectively). DL-CT and WB-MRI had significantly higher AUC than CT (p = 0.04 and p = 0.03). DL-CT significantly increased sensitivity compared to CT (0.89 vs. 0.79, p = 0.04). WB-MRI had significantly higher specificity than CT (0.84 vs. 0.96, p = 0.001) and DL-CT (0.87 vs. 0.96, p = 0.02).
Conclusions
DL-CT showed significantly higher per-lesion diagnostic performance and sensitivity than CT and WB-MRI. On a per-patient basis, DL-CT and WB-MRI had equal diagnostic performance superior to CT.
Key Points
• Spectral CT has higher diagnostic performance for diagnosing breast cancer metastases compared to conventional CT and whole-body MRI on a per-lesion basis.
• Spectral CT and whole-body MRI are superior to conventional CT for diagnosing patients with metastatic breast cancer.
• Whole-body MRI is superior to conventional CT and spectral CT for diagnosing bone metastases.
Similar content being viewed by others
Abbreviations
- ADC:
-
Apparent diffusion coefficient
- AUC:
-
Area under the curve
- DE-CT:
-
Dual-energy computed tomography
- DL-CT:
-
Dual-layer detector spectral computed tomography
- DWI:
-
Diffusion-weighted imaging
- DWIBS:
-
Diffusion-weighted whole-body imaging with background body signal suppression
- PET/CT:
-
Positron emission tomography/computed tomography
- ROC:
-
Receiver operating characteristics
- WB-MRI:
-
Whole-body magnetic resonance imaging
References
Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424
Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68:7–30
Cardoso F, Kyriakides S, Ohno S et al (2019) Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 30:1194–1220
Khatcheressian JL, Hurley P, Bantug E et al (2013) Breast cancer follow-up and management after primary treatment: American society of clinical oncology clinical practice guideline update. J Clin Oncol 31:961–965
Cardoso F, Senkus E, Costa A et al (2018) 4th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 4). Ann Oncol 29:1634–1657
Haraldsen A, Bluhme H, Røhl L et al (2016) Single photon emission computed tomography (SPECT) and SPECT/low-dose computerized tomography did not increase sensitivity or specificity compared to planar bone scintigraphy for detection of bone metastases in advanced breast cancer. Clin Physiol Funct Imaging 36:40–46
Hamaoka T, Madewell JE, Podoloff D a et al (2004) Bone imaging in metastatic breast cancer. J Clin Oncol 22:2942–2953
Hildebrandt MG, Gerke O, Baun C et al (2016) [181F] Fluorodeoxyglucose (FDG)-positron emission tomography (PET)/computed tomography (CT) in suspected recurrent breast cancer: a prospective comparative study of dual-time-point FDG-PET/CT, contrast-enhanced CT, and bone scintigraphy. J Clin Oncol 34:1889–1897
Yang HL, Liu T, Wang XM et al (2011) Diagnosis of bone metastases: a meta-analysis comparing 18FDG PET, CT, MRI and bone scintigraphy. Eur Radiol 21:2604–2617
Jambor I, Kuisma A, Ramadan S et al (2016) Prospective evaluation of planar bone scintigraphy, SPECT, SPECT/CT, 18F-NaF PET/CT and whole body 1.5T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial. Acta Oncol 55:59–67
Takahara T, Yamashita T (2003) Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med 22:275–282
Padhani AR, Liu G, Mu-Koh D et al (2009) Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 11:102–125
Kosmin M, Padhani AR, Gogbashian A et al (2020) Comparison of whole-body MRI, CT, and bone scintigraphy for response evaluation of cancer therapeutics in metastatic breast cancer to bone. Radiology. 297:622–629
Padhani AR, Lecouvet FE, Tunariu N et al (2017) METastasis reporting and data system for prostate cancer: practical guidelines for acquisition, interpretation, and reporting of whole-body magnetic resonance imaging-based evaluations of multiorgan involvement in advanced prostate cancer [figure presente. Eur Urol 71:81–92
Johnson TRC, Krauß B, Sedlmair M et al (2007) Material differentiation by dual energy CT: initial experience. Eur Radiol 17:1510–1517
Fredenberg E (2018) Spectral and dual-energy X-ray imaging for medical applications. Nucl Instruments Methods Phys Res Sect A Accel Spectrometers, Detect Assoc Equip 878:74–87
Carmi R, Naveh G, Altman A (2005) Material separation with dual-layer CT. IEEE Nucl Sci Symp Conf Rec 4:1876–1878
McCollough CH, Leng S, Yu L, Fletcher JG (2015) Review: dual-and multi-energy CT. RSNA Radiology 276:637–653
Simons D, Kachelrieß M, Schlemmer HP (2014) Recent developments of dual-energy CT in oncology. Eur Radiol 24:930–939
Abdullayev N, Große Hokamp N, Lennartz S et al (2019) Improvements of diagnostic accuracy and visualization of vertebral metastasis using multi-level virtual non-calcium reconstructions from dual-layer spectral detector computed tomography. Eur Radiol 29:5941–5949
Andersen MB, Ebbesen D, Thygesen J et al (2020) Impact of spectral body imaging in patients suspected for occult cancer: a prospective study of 503 patients. Eur Radiol 30:5539–5550
Pesapane F, Downey K, Rotili A et al (2020) Imaging diagnosis of metastatic breast cancer. Insights Imaging 11:79
Heusner TA, Kuemmel S, Koeninger A et al (2010) Diagnostic value of diffusion-weighted magnetic resonance imaging (DWI) compared to FDG PET/CT for whole-body breast cancer staging. Eur J Nucl Med Mol Imaging 37:1077–1086
Fausto A, Bernini M, Giacomo LD et al (2018) Diagnostic value and safety of dynamic MRI of contralateral breast and axilla in subjects with tissue expander. J Plast Reconstr Aesthet Surg 71:1282–1285
van Ommen F, de Jong HWAM, Dankbaar JW et al (2019) Dose of CT protocols acquired in clinical routine using a dual-layer detector CT scanner: a preliminary report. Eur J Radiol 112:65–71
van Ommen F, Bennink E, Vlassenbroek A et al (2018) Image quality of conventional images of dual-layer SPECTRAL CT: a phantom study. Med Phys 45:3031–3042
Fischer MA, Nanz D, Hany T et al (2011) Diagnostic accuracy of whole-body MRI/DWI image fusion for detection of malignant tumours: a comparison with PET/CT. Eur Radiol 21:246–255
Harris PA, Taylor R, Thielke R et al (2009) Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42:377–381
DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837–845
McNemar Q (1947) Note on the sampling error of the difference between correlated proportions or percentages. Psychometrika 12:153–157
Zhang X, Zheng C, Yang Z et al (2018) Axillary sentinel lymph nodes in breast cancer: quantitative evaluation at dual-energy CT. Radiology 289:337–346
Volterrani L, Gentili F, Fausto A et al (2020) Dual-energy CT for locoregional staging of breast cancer: preliminary results. AJR Am J Roentgenol 214:707–714
Chae EJ, Song JW, Seo JB et al (2008) Clinical utility of dual-energy CT in the evaluation of solitary pulmonary nodules: Initial experience. Radiology 249:671–681
Schmid-Bindert G, Henzler T, Chu TQ et al (2012) Functional imaging of lung cancer using dual energy CT: how does iodine related attenuation correlate with standardized uptake value of 18FDG-PET-CT? Eur Radiol 22:93–103
Acknowledgements
The authors would like to thank research radiographer Olga Vendelbo for helping set up scan protocols and scanning the patients.
Funding
This study was supported by the Health Research Foundation of Central Denmark Region.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Guarantor
Erik Morre Pedersen, MD PhD DMSc.
Conflict of Interest
The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.
Statistics and Biometry
No complex statistical methods were necessary for this paper.
Informed Consent
Prior to DL-CT and WB-MRI, written informed consent was obtained from all subjects (patients) in this study.
Ethical Approval
Institutional Review Board approval was obtained. This prospective single-centre study was approved by the Central Denmark Region Committee on Health Research Ethics (reference number 1-10-72-425-17) and was conducted between April 2018 and November 2019.
Methodology
• prospective
• diagnostic study
• performed at one institution
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
ESM 1
(DOCX 19 kb)
Rights and permissions
About this article
Cite this article
Buus, T.W., Rasmussen, F., Nellemann, H.M. et al. Comparison of contrast-enhanced CT, dual-layer detector spectral CT, and whole-body MRI in suspected metastatic breast cancer: a prospective diagnostic accuracy study. Eur Radiol 31, 8838–8849 (2021). https://doi.org/10.1007/s00330-021-08041-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-021-08041-2